NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $213,000 | -13.4% | 2,247 | -16.7% | 0.03% | -19.4% |
| Q2 2019 | $246,000 | -18.5% | 2,696 | -14.3% | 0.04% | -18.2% |
| Q1 2019 | $302,000 | +11.9% | 3,146 | 0.0% | 0.04% | -4.3% |
| Q4 2018 | $270,000 | -7.8% | 3,146 | -7.4% | 0.05% | +9.5% |
| Q3 2018 | $293,000 | -0.3% | 3,396 | -12.8% | 0.04% | -4.5% |
| Q2 2018 | $294,000 | -32.6% | 3,896 | -27.8% | 0.04% | -34.3% |
| Q1 2018 | $436,000 | -8.8% | 5,396 | -5.3% | 0.07% | -9.5% |
| Q4 2017 | $478,000 | -2.2% | 5,696 | 0.0% | 0.07% | -8.6% |
| Q3 2017 | $489,000 | +37.0% | 5,696 | -1.5% | 0.08% | +19.1% |
| Q2 2017 | $357,000 | -1.7% | 5,781 | +18.2% | 0.07% | -4.2% |
| Q1 2017 | $363,000 | -7.9% | 4,890 | -9.6% | 0.07% | -13.4% |
| Q4 2016 | $394,000 | – | 5,410 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |